The demonstration of anti-hypertensive substances in the urine

  • E. Tanner
  • H. Suter
  • J. Conti
  • J. Wanner
Conference paper

Abstract

Medical research constantly gives Man new medicaments which have the capacity to influence anatomical functions and controls in a way previously unsuspected.

Keywords

Gypsum Butanol Atropine Chlori Clarification 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Bäumeler und Rippstein: Pharm. Acta Helv. 36, 382 (1961).Google Scholar
  2. [1a]
    Liebich: Dtsch. Apoth.-Ztg. 99, 1246 (1959);Google Scholar
  3. [1aa]
    Liebich: Dtsch. Apoth.-Ztg. 100, 393 (1960).Google Scholar
  4. [1b]
    Nürnberg: Arch. Pharm. 292/64, 610 (1959).CrossRefGoogle Scholar
  5. Gänshirt: Arch. Pharm. 293/65, 925 (1960).CrossRefGoogle Scholar
  6. [2]
    Dollery, Emslie-Smith and Milne: Lancet (1960), No. 7147, 381.CrossRefGoogle Scholar
  7. [3]
    Experientia 14, 159–160 (1958).Google Scholar
  8. [4]
    Haycock, Sheth, Conolly and Mader: Journal of the association of official agricultural chemists Vol. 42, No. 3, 613 (1959).Google Scholar
  9. [5]
    Korzum, André and Ulshafer: J. Amer. pharm. Ass., sci. Ed. Vol. XLVI, No. 12, 720 (1957).Google Scholar
  10. [6]
    André, Korzum and Weinfeldt: J. org. Chemistry 21, 480 (1956).CrossRefGoogle Scholar
  11. [7]
    Baer, Paulson, Russo and Beyer: Amer. J. Physiol. 186, 180–186 (1956).PubMedGoogle Scholar
  12. [8]
    Zeimis: Brit. J. Pharmacol. 5, 424–430 (1950).Google Scholar
  13. [9]
    Harington: Clin. Sci. 12, 185–198 (1953).PubMedGoogle Scholar
  14. [10]
    Sheppard, Sachs D’Asaro: Nature 177, 1089 (1956).CrossRefGoogle Scholar
  15. [11]
    Perry: J. Lab. clin. Med. 41, 566–573 (1953).PubMedGoogle Scholar
  16. [12]
    Sheppard, Plummer and Sabbagh: Fed. Proc. 15, 483 (1956).Google Scholar
  17. [13]
    Tompsett, Forshall and Smith: Acta pharmacol. (Kbh.) 18, 75–79 (1961).CrossRefGoogle Scholar
  18. [14]
    Rosenheim et al.: Lancet No. 7089, 17 (1959).Google Scholar
  19. [15]
    Haycock, Sheth and Mader: J. Amer. pharm. Ass., sci. Ed. Vol. XLVIII, No. 8, 479 (1959).Google Scholar
  20. [16]
    Sheppard, Wagle and Plummer: Fed. Proc. 13, 404 (1954).Google Scholar
  21. [17]
    Stahl: Pharmazie 11, 633 (1956);PubMedGoogle Scholar
  22. [17a]
    Stahl: Chemiker-Ztg. 82, 323 (1958);Google Scholar
  23. [17b]
    Stahl: Parfumerie u. Kosmet. 9, 564 (1958).Google Scholar
  24. [18]
    Cuzzoni: Pharmaco, ed. pract. 12, 204 (1957).Google Scholar
  25. [18a]
    Bayer: Pharmazie 13, 468 (1958).PubMedGoogle Scholar
  26. [18b]
    Krebs: Dtsch. Apoth.-Ztg. 98, 1341 (1958).Google Scholar
  27. [19]
    Tanner, Suter, Conti und Wanner: Lebensversicher.-Med. 13, 69–71 (1961).Google Scholar

Copyright information

© Springer-Verlag OHG Berlin · Göttingen · Heidelberg 1962

Authors and Affiliations

  • E. Tanner
  • H. Suter
  • J. Conti
  • J. Wanner

There are no affiliations available

Personalised recommendations